ITEM 8.01 OTHER EVENTS.

On June 9, 2021, Pulse Biosciences, Inc. issued a press release announcing the approval of its proprietary CellFX? System by Health Canada for use in dermatological procedures requiring ablation and resurfacing of the skin for the reduction, removal, and/or clearance of cellular-based benign lesions. A copy of this press release is attached as Exhibit 99.1.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS



            (d)  Exhibits.

Exhibit No.     Description
  99.1            Press Release issued by Pulse Biosciences, Inc. dated June 9, 2021.
104             Cover Page Interactive Data File (embedded within the Inline XBRL document)



?

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses